Ergul, Adviye, Vera Portik-Dobos, Ararat D. Giulumian, Mariela M. Molero, and Leslie C. Fuchs. Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am J Physiol Heart Circ Physiol 285: H2225-H2232, 2003. First published July 3, 2003 10.1152/ajpheart.00133.2003.-Degradation of the extracellular matrix proteins by matrix metalloproteinases (MMP) is an important regulatory step in the vascular remodeling process. Recent studies demonstrated that ETA receptors regulate cardiac MMP activity and fibrosis in DOCA-salt hypertension. However, little is known about endothelin (ET)-1 regulation of vascular MMP activity in hypertension. Thus early changes in ET-1-mediated regulation of MMP activity were measured in borderline hypertensive rats that develop impaired vasorelaxation and hypertension with chronic exposure to stress. Experiments were performed after 10 days of exposure to the behavioral stressor, air-jet stress, but before the onset of stress-induced hypertension. Study groups were 1) control (n ϭ 8); 2) air-jet stress for 10 days (n ϭ 8); 3) control plus ETA antagonist ABT-627 (n ϭ 4), and 4) air-jet stress plus ET A antagonist (n ϭ 4). MMP activity in the thoracic aorta was assessed by gelatin zymography. MMP protein and tissue ET-1 levels were evaluated by immunohistochemistry, and ET receptor density was determined by immunoblotting. Exposure to stress caused a twofold increase in plasma ET-1 levels (P Ͻ 0.05), and there was increased ET-1 staining at the tissue level. Total MMP activity and expression of MMP-2 and MMP-9 were increased in the stress group. ETA receptor antagonism prevented the increase in MMP expression and activation in the stress group. These results provide evidence that the MMP system is activated before the development of hypertension and ET-1 mediates these early events in vascular remodeling.endothelin-1; ABT-627 ENDOTHELIN-1 (ET-1) contributes to blood pressure elevation as well as cardiac, vascular, and renal complications in several experimental models, including DOCA-salt hypertensive rat, DOCA-salt-treated spontaneously hypertensive rats (SHRs), Dahl salt-sensitive rats, and aldosterone-infused rats (18,21,24,25). In DOCA-salt hypertensive rats, enhanced myocardial remodeling and fibrosis associated with increased fibronectin, matrix metalloproteinase (MMP) activity, and proinflammatory mediators occur in the left ventricle and ET A receptor antagonism inhibits these changes (1, 2). In clinical hypertension, ET-1 is increased in African-American hypertensive patients who present with increased incidence of cardiovascular complications, including left ventricle hypertrophy and stroke (7,8). Although the exact mechanism is not clear, it has been proposed that African-Americans experience chronic sympathetic system activation due to more recurrent exposure to social and environmental stress, which contribute to the increased incidence of hypertension and related complications in this patient population (9). A recent stud...